Submissions from 2023
“Cardiorenal Disease: Can reducing the risks improve outcomes?”, Katherine Tuttle
Chair – Targeting Muscle, Kidney & Liver, Katherine Tuttle
Clinicopathologic Conference “ Nephrotic Syndrome”, Katherine Tuttle
“Comparative effectiveness of GLP-1 receptor agonists vs DPP-4 inhibitors in patients type 2 diabetes, Katherine Tuttle
“Comparative effectiveness of GLP-1 receptor agonists vs. SGLT2 inhibitors”, Katherine Tuttle
Destination Kidney Health for Diabetes and CKD, Katherine Tuttle
Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors., Katherine Tuttle
Effects of Long COVID, Katherine Tuttle
“FDA Approved Empagliflozin for Adults with Chronic Kidney Disease at Risk of Progression”, Katherine Tuttle
“FDA approves new indication for Jardiance”, Katherine Tuttle
“GLP1 RAs and Kidney Outcomes in Diabetes”, Katherine Tuttle
Harvard Medical School – Diabetes Comorbidities and Complications, Katherine Tuttle
“Implementation of a New Era of Goal-Directed Medical Therapy for Patients with Cardiorenal Disease”, Katherine Tuttle
“Incretin Trials: Trying new directions”, Katherine Tuttle
“Jardiance approved for adults with Chronic Kidney Disease”, Katherine Tuttle
KDIGO Conference on CKD, Rome Italy, Katherine Tuttle
Late breaking clinical trials: “Asi in CKD”, Katherine Tuttle
Most Powerful Tools Ever to Slow the Progression of Diabetic Kidney Disease: How and When to Use them Optimally”, Katherine Tuttle
Multidisciplinary Strategies for Implementation, Katherine Tuttle
National Academies of Sciences, Engineering, and Medicine, Preparing the Future Workforce in Drug Research and Development Workshop – Speaker, Katherine Tuttle
“ Non-insulin therapies for people living with T2D”, Katherine Tuttle
“On par with the biggest breakthroughs in medicine”, Katherine Tuttle
“Outsize benefit seen in trial of drug for kidney disease”, Katherine Tuttle
“Prediction of kidney failure using multiple data domains in glomerulonephropathy: A CureGN study”, Katherine Tuttle
“Preserving Kidney Health in Diabetes”, Katherine Tuttle
Protective effects of GLP-1 Receptor Agonists, Katherine Tuttle
Providence IM/FM Resident’s Lecture “CKD in Diabetes and Beyond. Entering A New Era of Kidney Health” Spokane, WA, Katherine Tuttle
“Racial and Ethnic Disparities in Acute Care Utilization Among Patients with Glomerular Disease”, Katherine Tuttle
"Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes", Katherine Tuttle
Research presented at the American Society of Nephrology meeting, Katherine Tuttle
“Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease”, Katherine Tuttle
“Scientists find promising new drug for chronic kidney disease”, Katherine Tuttle
“SGLT2 inhibitors and GLP-1 receptor agonist: mechanisms of beneficial action beyond, Katherine Tuttle
“Spokane doctor’s breakthrough kidney disease treatment shows promising results”, Katherine Tuttle
“The Journey to Kidney Health is the Reward for People with Diabetes and CKD”, Katherine Tuttle
“The Kidney | SGLT2 Inhibitors and GLP-1”, Katherine Tuttle
“Therapeutic Transformation of Kidney Care by Groundbreaking Clinical Trials”, Katherine Tuttle
“There is no excuse for the number of people we have on dialysis”, Katherine Tuttle
“Tirzepaztide reduces albuminuria in patients with type 2 diabetes”, Katherine Tuttle
“Unmet need: The epidemiology of CKD & type 1 diabetes”, Katherine Tuttle
USPSTF Kidney Caucus Meeting - Speaker, Katherine Tuttle
A Quality Improvement Initiative to Bridge Gaps in Treatment and Interprofessional Care of CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Research Diversity (AIM-AHEAD), Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Assessment of Medication Adherence Among Adults with Glomerular Disease, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerernone on Kidney Disease Progression in People with non-diabetic CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Diabetic Kidney Disease Collaborative (DKD-C): Addressing the Urgent and Unmet Needs of People with CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Dynamic Bayesian Networks (DBN) Predicted ≥40% Decline in eGFR over Six Years, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Incidence of Chronic Kidney Disease in Prediabetes, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Interim Results from FINE-REAL: A Prospective Study Providing Insights into the Use of Finerenone in Routine Clinical Settings, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Kidney Failure Risk Equation Prediction in a Real-World Population with CKD, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Kidney Transcriptomics of Blood Pressure (BP) in Minimal Change Disease (MDC) and Focal Segmental Glomerulosclerosis (FSGS), Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Major Adverse Kidney Disease Events in a Real-World Population with Diabetes, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Predictors of Major Adverse Kidney Disease Events in a Real-World Population with IgA Nephropathy, Katherine Tuttle, Radica Alicic, Cami Jones, Lindsey Kornowske, Kenn Daratha, and See full list of authors in comments
Predictors of major adverse kidney disease in a real-world population with IgA nephropathy, Katherine Tuttle, Ken Daratha, Radica Alicic, Joshua J Neumiller, and See all authors in comments
Major adverse kidney disease events in a real-world population with diabetes, Katherine Tuttle, Ken Daratha, Joshua J Neumiller, Radica Alicic, and See all authors in comments
Kidney-Heart Connection: Implications of Chronic Kidney Disease for Screening and Prevention of Heart Failure., Katherine Tuttle and Carolyn S P Lam
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo., Katherine R Tuttle, Heidrun Bosch-Traberg, David Z I Cherney, Samy Hadjadj, Jack Lawson, Ofri Mosenzon, Søren Rasmussen, and Stephen C Bain
The authors reply., Katherine R Tuttle, Heidrun Bosch-Traberg, David Z I Cherney, Samy Hadjadj, Ofri Mosenzon, Søren Rasmussen, and Stephen C Bain
Comparative effectiveness of GLP-1 receptor agonists vs DPP-4 inhibitors in patients with type 2 diabetes and moderate/severe chronic kidney disease, Katherine Tuttle and See all authors in comments
Diabetic Kidney Disease Collaborative (DKD-C): Addressing the urgent and unmet needs of people with chronic kidney disease and diabetes, Katherine Tuttle and See all authors in comments
Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide., Katherine Tuttle, Jonathan Matthew Wilson, Yanzhu Lin, Hui-Rong Qian, Federica Genovese, Morten Asser Karsdal, Kevin L Duffin, and Fady T Botros
Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide., Katherine Tuttle, Jonathan Matthew Wilson, Yanzhu Lin, Hui-Rong Qian, Federica Genovese, Morten Asser Karsdal, Kevin L Duffin, and Fady T Botros
Changing Landscape of Diabetic Kidney Disease Treatment, including the Robert W. Schrier, MD, Endowed Lectureship, Katherine Tuttle (moderator)
End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study., Alexandra C van Dissel, Alexander R Opotowsky, Luke J Burchill, Jamil Aboulhosn, Jasmine Grewal, Adam M Lubert, Petra Antonova, Sangeeta Shah, Timothy Cotts, Anitha S John, William Aaron Kay, Christopher DeZorzi, Anthony Magalski, Frank Han, David Baker, Joseph Kay, Elizabeth Yeung, Isabelle Vonder Muhll, Stephen Pylypchuk, Marissa C Kuo, Jeremy Nicolarsen, Berardo Sarubbi, Flavia Fusco, Susan M Jameson, Jonathan Cramer, Tripti Gupta, Pastora Gallego, Clare O'Donnell, Jane Hannah, Mikael Dellborg, Robert M Kauling, Salil Ginde, Eric V Krieger, Fred Rodriguez, Payam Dehghani, Shelby Kutty, Joshua Wong, William M Wilson, Carla P Rodriguez-Monserrate, Jolien Roos-Hesselink, David S Celermajer, Paul Khairy, and Craig S Broberg
Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study., Chia-Shi Wang, Dorey A Glenn, Margaret Helmuth, Abigail R Smith, Andrew S Bomback, Pietro A Canetta, Gaia M Coppock, Myda Khalid, Katherine Tuttle, Raed Bou-Matar, Larry A Greenbaum, Bruce M Robinson, Lawrence B Holzman, William E Smoyer, Michelle N Rheault, Debbie Gipson, Laura H Mariani, and Cure Glomerulonephropathy (CureGN) Study Consortium
Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study., Linda Wang, Bayle Smith-Salzberg, Kevin Ec Meyers, Dorey A Glenn, Katherine Tuttle, Vimal K Derebail, Tammy M Brady, Keisha Gibson, Abigail R Smith, Michelle M O'Shaughnessy, Tarak Srivastava, Gentzon Hall, Jarcy Zee, Markus Bitzer, and Christine B Sethna
Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study., Linda Wang, Bayle Smith-Salzberg, Kevin Ec Meyers, Dorey A Glenn, Katherine R Tuttle, Vimal K Derebail, Tammy M Brady, Keisha Gibson, Abigail R Smith, Michelle M O'Shaughnessy, Tarak Srivastava, Gentzon Hall, Jarcy Zee, Markus Bitzer, and Christine B Sethna
Root Cause Analysis, Victor Warr, Tom Sant, Carly Riehl, and Rahib Bashir
Procedure 19: Chest Tube Removal (Perform), Julie M. Waters
Procedure 20: Chest Tube Removal (Assist), Julie M. Waters
Procedure 29: Manual Self-Inflating Resuscitation Bag-Valve-Mask Device, Kim Wigen-Dewey
Breastfeeding Disparities Among Rural Breastfeeding Dyads in High-Income Countries: A Scoping Study., Natsuko K Wood, Rebecca Penders, and Ann M Dyer
Advances in Chronic Kidney Disease Care in Type 2 Diabetes, Carol Wysham and Katherine Tuttle
Assessing Spokane Psychiatry Department's Knowledge of Outpatient Psychiatry Resources and Discharge Planning Practices, Pong Xiong and Richard Carlson
Value and Ongoing Quality Improvement of the Journal Club in IM Residency, Kang X Zhang and Cody Howdeshell
Submissions from 2022
Use of Glucose-Lowering Agents in Diabetes and CKD., Radica Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine Tuttle
Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century., Radica Alicic and Susanne B Nicholas
Use of Glucose-Lowering Agents in Diabetes and CKD., Radica Z Alicic, Joshua J Neumiller, Rodolfo J Galindo, and Katherine R Tuttle
Management of Transhepatic Cholangioscopy: A Case Series, Drew Anderson, Jeffrey Forris Beecham, David S. Shin, and Ravi Srinivasa
A Simple Critical Care Provider Transfusion Education Program Reduces Blood Product Use, Ivan Martinez Avalos, Stephen Malkoski, and Mellody Descoteaux
CKD Series Episode 1: Identifying Patients at Risk for DKD Onset or Progression, George Bakris, Rajiv Agarwal, and Katherine Tuttle
CKD Series Episode 2: Counseling Patients about CKD, George Bakris, Rajiv Agarwal, and Katherine Tuttle
CKD Series Episode 3: Updated Approach to Managing CKD in Patients with T2DM, George Bakris, Rajiv Agarwal, and Katherine Tuttle
CKD Series Episode 4: Implications of Non-steroidal MRAs for DKD, George Bakris, Rajiv Agarwal, and Katherine Tuttle
CKD Series Episode 5: New and Emerging Therapies and Approaches for CKD, George Bakris, Rajiv Agarwal, and Katherine Tuttle
Safety and Feasibility of Photodynamic Therapy for Ablation of Peripheral Lung Tumors., Sandeep Bansal, Rabih I Bechara, Jiten D Patel, Hiren J Mehta, J Scott Ferguson, Benjamin L Witt, Septimiu D Murgu, Kazuhiro Yasufuku, and Roberto F Casal
Ethics Roundtable: "Organ Donation After Cardiac Death" in a Patient with Developmental Delay., Steven J Baumrucker, Matt Stolick, Scott P Boyles, Vladlena Jefferson, Eddy R Smith, and Gregory T Carter
Content and complexity of consultations in a provider-to-provider perinatal psychiatry consultation line: A mixed methods analysis., Amritha Bhat, Farah Khan, Mariyam Shaikh, Natalie Franz, Alicia Kerlee, Jamie Adachi, Carmen Croicu, Kelly Wurzel, and Deborah Cowley
Temporal trends and predictors of surgical ablation for atrial fibrillation across a multistate healthcare system., Scott Brancato, Mansen Wang, Kateri Spinelli, Maheer Gandhavadi, Neil Worrall, Eric J Lehr, Zachary M DeBoard, Torin P. Fitton, Alison Leiataua, Jonathan P Piccini, and Tyler J Gluckman
Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia., Leonardo R Brandão, Igor Tartakovsky, Manuela Albisetti, Jacqueline Ml Halton, Lisa Bomgaars, Elizabeth Chalmers, Matteo Luciani, Paola Saracco, Judy Felgenhauer, Olga Lvova, Monika Simetzberger, Zhichao Sun, and Lesley G Mitchell
Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries., Craig S Broberg, Alexandra van Dissel, Jessica Minnier, Jamil Aboulhosn, Robert M Kauling, Salil Ginde, Eric V Krieger, Fred Rodriguez, Tripti Gupta, Sangeeta Shah, Anitha S John, Timothy Cotts, W Aaron Kay, Marissa Kuo, Cindy Dwight, Patricia Woods, Jeremy Nicolarsen, Berardo Sarubbi, Flavia Fusco, Petra Antonova, Susan Fernandes, Jasmine Grewal, Jonathan Cramer, Paul Khairy, Pastora Gallego, Clare O'Donnell, Jane Hannah, Mikael Dellborg, Carla P Rodriguez-Monserrate, Isabelle Vonder Muhll, Stephen Pylypchuk, Anthony Magalski, Frank Han, Adam M Lubert, Joseph Kay, Elizabeth Yeung, Jolien Roos-Hesselink, David Baker, David S Celermajer, Luke J Burchill, William M Wilson, Joshua Wong, Shelby Kutty, and Alexander R Opotowsky
A Case of Potential Pharmacokinetic Kratom-drug Interactions Resulting in Toxicity and Subsequent Treatment of Kratom Use Disorder With Buprenorphine/Naloxone., Hazel Brogdon, Mackenzie M McPhee, Mary F Paine, Emily J Cox, and Amy G Burns
Motivational Interviewing: Curriculum and Assessment in a Time Requiring Epic Behavior Change, Amy Burns
Motivational Interviewing in Physician Education, Amy Burns
Risk of Secondary Malignancies in Ovarian Cancer Survivors: 54,305 Patients Analyzed With 40 Years of Follow-up, A C. Casper, M W. Parsons, J Chipman, L M. Burt Jr, G Suneja, K A. Maurer, and D K. Gaffney
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR:, David Z I Cherney, Samy Hadjadj, Jack Lawson, Ofri Mosenzon, Katherine Tuttle, Blaz Vrhnjak, Søren Rasmussen, and Stephen C Bain
Gross contamination of an anesthesia machine., Alex Chung, Landon Woolf, Elena Adler, and Michale Ok
Case Series Conference: Anesthetic Management in Parturients With Fontan Physiology., Daniel E Clark, Genevieve Staudt, Ryan D Byrne, Christina Jelly, Karla Christian, Susan D Dumas, Steven Healan, Benjamin P Frischhertz, Jennifer Thompson, Angela J Weingarten, and Susan Eagle
Improving Metabolic Monitoring during Transfers of Care for Psychiatric Patients Discharged from the Inpatient Psychiatric Residency Service on an Antipsychotic Medication, Allison Cohen and Anisha Boetel
Contingency Management: Dealing Abstinence from Methamphetamines, Casey Collins, Amy G Burns, Lindsey Cunningham, and Brenda Fairman
